Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Guidance Gives Best Practices For Bench-Test Reports

Executive Summary

A new FDA draft guidance makes recommendations on what information medical device sponsors should include in complete test reports for nonclinical bench-testing as part of pre-market submissions.

You may also be interested in...



Final Bench Testing Guidance Clarifies FDA Expectations

Device developers are getting new guidance about what the US FDA wants to see from non-clinical bench testing via a final guidance document issued on 25 April.

Global Medtech Guidance Tracker: May 2018

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-six new guidance documents were posted on the tracker since its last update.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel